Chris M. Teigland

719 total citations
22 papers, 466 citations indexed

About

Chris M. Teigland is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Chris M. Teigland has authored 22 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Chris M. Teigland's work include Renal cell carcinoma treatment (6 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Prostate Cancer Treatment and Research (4 papers). Chris M. Teigland is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Prostate Cancer Treatment and Research (4 papers). Chris M. Teigland collaborates with scholars based in United States, Italy and Germany. Chris M. Teigland's co-authors include Richard L. White, James H. Zuger, David E. Kang, Howell Sasser, Kent W. Kercher, Amy E. Lincourt, B. Todd Heniford, Claus G. Roehrborn, Lon Eskind and Brent D. Matthews and has published in prestigious journals such as The Journal of Urology, European Urology and CA A Cancer Journal for Clinicians.

In The Last Decade

Chris M. Teigland

22 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris M. Teigland United States 10 280 139 113 85 84 22 466
J. Wylie United Kingdom 13 219 0.8× 134 1.0× 136 1.2× 87 1.0× 126 1.5× 30 552
See Hyung Kim South Korea 14 266 0.9× 202 1.5× 219 1.9× 78 0.9× 122 1.5× 61 576
Stephan Jeschke Austria 10 416 1.5× 179 1.3× 87 0.8× 53 0.6× 43 0.5× 19 569
Blanca Paño Spain 11 325 1.2× 170 1.2× 179 1.6× 118 1.4× 53 0.6× 22 540
Özgür Yaycıoğlu Türkiye 15 369 1.3× 226 1.6× 33 0.3× 140 1.6× 40 0.5× 43 621
Mitsuhiro Tambo Japan 12 194 0.7× 131 0.9× 49 0.4× 62 0.7× 92 1.1× 45 409
Hirotaka Akita Japan 12 325 1.2× 225 1.6× 150 1.3× 151 1.8× 50 0.6× 34 596
R. Minervini Italy 13 299 1.1× 254 1.8× 35 0.3× 191 2.2× 53 0.6× 40 534
Sebastian Frees Germany 13 212 0.8× 146 1.1× 48 0.4× 126 1.5× 93 1.1× 37 445
Y. Ahallal Morocco 12 379 1.4× 198 1.4× 46 0.4× 25 0.3× 39 0.5× 50 524

Countries citing papers authored by Chris M. Teigland

Since Specialization
Citations

This map shows the geographic impact of Chris M. Teigland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris M. Teigland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris M. Teigland more than expected).

Fields of papers citing papers by Chris M. Teigland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris M. Teigland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris M. Teigland. The network helps show where Chris M. Teigland may publish in the future.

Co-authorship network of co-authors of Chris M. Teigland

This figure shows the co-authorship network connecting the top 25 collaborators of Chris M. Teigland. A scholar is included among the top collaborators of Chris M. Teigland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris M. Teigland. Chris M. Teigland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaston, Kris E., et al.. (2020). Safety and effectiveness of percutaneous renal cryoablation with conscious sedation. Arab Journal of Urology. 18(3). 163–168. 3 indexed citations
2.
Teigland, Chris M., et al.. (2016). Reducing the Incidence of Retained Double-J Ureteral Stents: A Multidisciplinary Approach. Urology Practice. 3(5). 325–331. 6 indexed citations
4.
Tinelli, Andrea, Antonio Malvası, Daniel A. Tsin, et al.. (2012). Surgical Management of Neurovascular Bundle in Uterine Fibroid Pseudocapsule. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 16(1). 119–129. 32 indexed citations
5.
Mettler, Liselotte, Andrea Tinelli, Chris M. Teigland, et al.. (2011). Neurovascular bundle in fibroid pseudocapsule and its neuroendocrinologic implications. Expert Review of Endocrinology & Metabolism. 6(5). 715–722. 12 indexed citations
7.
Hope, William W., B. Todd Heniford, H. James Norton, et al.. (2009). Duration and Clinical Significance of Radiographically Detected “Free Air” After Laparoscopic Nephrectomy. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 19(5). 415–418. 6 indexed citations
8.
Kercher, Kent W., Marc Zerey, B. Todd Heniford, et al.. (2008). Strategies in the management of renal tumors amenable to partial nephrectomy. Surgical Endoscopy. 23(9). 2161–2166. 2 indexed citations
9.
Kercher, Kent W., et al.. (2008). Hand-assisted laparoscopic partial nephrectomy after 60 cases: comparison with open partial nephrectomy. Surgical Endoscopy. 23(5). 1075–1080. 15 indexed citations
10.
Peretsman, Samuel J., et al.. (2007). Castleman Disease of the Hyaline-Vascular Type Confined to the Kidney. American Journal of Clinical Pathology. 127(3). 465–468. 15 indexed citations
11.
Greene, Frederick L., et al.. (2007). Minimal Access Cancer Management. CA A Cancer Journal for Clinicians. 57(3). 130–146. 19 indexed citations
12.
Peretsman, Samuel J., et al.. (2007). Castleman Disease of the Hyaline-Vascular Type Confined to the Kidney. American Journal of Clinical Pathology. 127(3). 465–468. 1 indexed citations
13.
Gaston, Kris E., et al.. (2007). Nephron-Sparing Radical Excision of a Giant Perirenal Liposarcoma Involving a Solitary Kidney. The American Surgeon. 73(4). 377–380. 3 indexed citations
14.
Cella, David, Daniel P. Petrylak, Mayer Fishman, et al.. (2006). Role of Quality of Life in Men with Metastatic Hormone-Refractory Prostate Cancer: How Does Atrasentan Influence Quality of Life?. European Urology. 49(5). 781–789. 21 indexed citations
15.
Kang, David E., Richard L. White, James H. Zuger, Howell Sasser, & Chris M. Teigland. (2004). Clinical Use of Fluorodeoxyglucose F 18 Positron Emission Tomography for Detection of Renal Cell Carcinoma. The Journal of Urology. 171(5). 1806–1809. 196 indexed citations
16.
Eskind, Lon, Chris M. Teigland, Brent D. Matthews, et al.. (2003). Laparoscopic versus open nephrectomy in 210 consecutive patients: Outcomes, cost, and changes in practice patterns. Surgical Endoscopy. 17(12). 1889–1895. 70 indexed citations
19.
Roehrborn, Claus G., Chris M. Teigland, & Arthur I. Sagalowsky. (1987). Functional Characteristics of the Camey Ileal Bladder. The Journal of Urology. 138(4 Part 1). 739–742. 22 indexed citations
20.
Teigland, Chris M., Ralph V. Clayman, Howard N. Winfield, & Ross J. Roeser. (1986). Ultrasonic Lithotripsy: The Risk of Hearing Loss. The Journal of Urology. 135(4). 728–729. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026